Diseases, Conditions, Syndromes

Pandemic leads to broader use of monoclonal antibodies

New cases of COVID-19 in the United States have dropped by about 75% from the latest peak in mid-January, but as of Feb. 14, the two-year-old pandemic had claimed more than 920,000 lives, more than in any other country. Even ...

Medications

Understanding the latest COVID-19 treatments

As the country set a record high for daily COVID-19 cases this week, new treatments like the Pfizer and Merck pills that help people avoid hospitalization couldn't come at a better time. For many, the approval of the new ...

Medications

Pfizer says COVID pill drastically reduces severe disease

Pfizer said Tuesday that clinical trials confirmed its COVID pill—a new type of treatment that should withstand the mutations seen with the Omicron variant—drastically reduced hospitalizations and deaths among at-risk ...

Medications

US panel backs first-of-a-kind COVID-19 pill from Merck

A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus.

page 10 from 38